Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype.
Elisabetta Pagani(Vita-Salute San Raffaele University), Massimo Filippi(Vita-Salute San Raffaele University), Vittorio Martinelli(Vita-Salute San Raffaele University), Marco Rovaris(San Raffaele University of Rome), Maria A. Rocca(Cognitive Neuroimaging Lab), Antonio Gallo(University of Campania "Luigi Vanvitelli"), Giancarlo Comi(Vita-Salute San Raffaele University)
PubMed
February 1, 2005
Cited by 179
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k